SCHEMBL7583285

SCHEMBL7583285

O=[N+]([O-])c1ccc(Oc2ccccc2)cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.51
KDM4E B2RXH2 1/20 0.50
LTA4H P09960 1/20 0.50
NR1H2 P55055 1/20 0.50
BAX Q07812 1/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
TTR P02766 1/20 0.47
ALB P02768 1/20 0.47
THRB P10828 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CTSB P07858 1/20 0.46
FFAR1 O14842 1/20 0.46
TLR4 O00206 3/20 0.46
TLR2 O60603 3/20 0.46
CRHBP P24387 3/20 0.45
CRHR2 Q13324 3/20 0.45
HPSE Q9Y251 1/20 0.44
SOS1 Q07889 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847049 0.93 GPR35 (0.58) GPR35KDM4EMEN1KMT2ATHRB
SCHEMBL4840927 0.92 GPR35 (0.53) GPR35KDM4ETHRBTDP1ALDH1A1
SCHEMBL4843320 0.87 GPR35 (0.51) GPR35KDM4EMEN1KMT2ATTR
SCHEMBL1602832 0.87 MAPK1 (0.51) GPR35KDM4ELTA4HNR1H2BAX
SCHEMBL4839671 0.86 GPR35 (0.55) GPR35KDM4EMEN1KMT2ATHRB
SCHEMBL5955410 0.85 LTA4H (0.52) GPR35LTA4HMEN1KMT2ATDP1
SCHEMBL10717379 0.84 ALDH1A1 (0.55) KDM4ELTA4HMEN1KMT2ATTR
SCHEMBL4841623 0.84 PTPN1 (0.50) GPR35KDM4ETDP1ALDH1A1SOS1
SCHEMBL6186809 0.84 GPR35 (0.49) GPR35KDM4EMEN1KMT2ATHRB
SCHEMBL4845296 0.84 GPR35 (0.49) GPR35KDM4EMEN1KMT2ATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0011802-B1 PHENOXY-PHENOXY-PROPIONIC ACID AMIDES, PROCESSES FOR THEIR PREPARATION, HERBICIDAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN CONTROLLING THE GROWTH OF WEEDS HOECHST AKTIENGESELLSCHAFT (DE) 1982-09-15 EP claimed
US-20260022122-A1 NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME CHECKMATE THERAPEUTICS INC. (KR) 2026-01-22 US disclosed
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
US-11883387-B2 PqsR inverse agonists Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2024-01-30 US disclosed
WO-2023229346-A1 NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME 주식회사 체크메이트테라퓨틱스 2023-11-30 WO disclosed
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 US disclosed
EP-3818045-A1 PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-05-12 EP disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 WO disclosed
EP-1013635-B1 Preparation of diphenylethers DOW AGROSCIENCES LLC (US) 2002-09-18 EP disclosed
EP-1013635-A1 Preparation of diphenylethers ROHM AND HAAS COMPANY (US) 2000-06-28 EP disclosed
EP-1013635-A1 Preparation of diphenylethers ROHM AND HAAS COMPANY (US) 2000-06-28 EP disclosed
EP-0011802-B1 PHENOXY-PHENOXY-PROPIONIC ACID AMIDES, PROCESSES FOR THEIR PREPARATION, HERBICIDAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN CONTROLLING THE GROWTH OF WEEDS HOECHST AKTIENGESELLSCHAFT (DE) 1982-09-15 EP disclosed
EP-0011802-A1 Phenoxy-phenoxy-propionic acid amides, processes for their preparation, herbicidal compositions containing them and their use in controlling the growth of weeds HOECHST AKTIENGESELLSCHAFT (DE) 1980-06-11 EP disclosed
EP-0011802-A1 Phenoxy-phenoxy-propionic acid amides, processes for their preparation, herbicidal compositions containing them and their use in controlling the growth of weeds HOECHST AKTIENGESELLSCHAFT (DE) 1980-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11883387-B2 PqsR inverse agonists QRFPR, P2RY11, QARS1 GPR35 11/4885KDM4E 3629/4885LTA4H 1192/4885
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 GPR35 11/4885KDM4E 3629/4885LTA4H 1192/4885
US-20260022122-A1 NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME NAMPT, NAPRT, NNT GPR35 2281/4885KDM4E 2601/4885LTA4H 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.